Scandinavian Biolabs (SBL), a Danish innovator within the haircare business, introduced the closing of a €4 million funding spherical led by Auréa Group marking a major milestone alongside the corporate’s development journey. Auréa joins current buyers Blazar Capital on the board of SBL.
Based in 2020, Scandinavian Biolabs has established itself as a pacesetter in science-backed, non-invasive, preventative merchandise concentrating on early-stage hair loss. The corporate’s flagship product, the Bio-Pilixin® Activation Serum, has been a game-changer available in the market, and has been clinically examined for its constructive results.
Scandinavian Biolabs initially launched as a direct-to-consumer (DTC) model, quickly constructing a loyal buyer base via its on-line platform. Constructing on this success, the model has expanded into retail, and varied pharmacies throughout a number of geographies.
Anders Reckendorff, CEO and Co-Founding father of Scandinavian Biolabs, stated: “We’ve constructed a powerful basis with our revolutionary merchandise and confirmed that if we will present our prospects worth and outcomes, we can even have a powerful enterprise. We’re excited to be joined by our new buyers who may help us leapfrog our development via their expertise and know-how.”
With over 140,000 prospects supported to date, and a Trustpilot rating of 4.5 out of 5, Scandinavian Biolabs is on a quick observe to turn out to be the popular resolution for dependable, examined and sincere hair-care merchandise that work together with your physique. SevenVentures (A part of Professional. SiebenSat.1 Group) is supporting the German growth via a strategic TV collaboration.
The €4 million money infusion from Auréa will allow Scandinavian Biolabs to pursue its bold development plans extra aggressively forging a management place within the UK, Germany, and the Nordics, whereas additionally coming into the US market, scaling the enterprise via a web-based providing, and increasing strategic retail comparable to pharmacies.
Auréa Fund commented: “Auréa is delighted to have been chosen by the Scandinavian Biolabs as their most well-liked investor for the expertise and operational value-add that we deliver along with the expansion capital. We consider within the founders and the really differentiated and efficacious merchandise that they’ve developed. We’re assured that collectively we’ll scale this into a major worldwide model.”
